Comparison of palonosetron and granisetron in triplet antiemetic therapy in nonmetastatic breast cancer patients receiving high emetogenic chemotherapy. A multicenter, prospective, and observational study

Araz, M.Karaagac, M.Korkmaz, L.Koral, L.Inci, F.Beypinar, I.Uysal, M.2025-01-272025-01-2720180923-75341569-8041https://hdl.handle.net/20.500.12428/2796843rd ESMO Congress (ESMO) -- OCT 19-23, 2018 -- Munich, GERMANY[Anstract Not Available]eninfo:eu-repo/semantics/closedAccessComparison of palonosetron and granisetron in triplet antiemetic therapy in nonmetastatic breast cancer patients receiving high emetogenic chemotherapy. A multicenter, prospective, and observational studyConference Object29636636Q1WOS:000459277304157